Maitreya Medicare Limited — Others, 30-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Maitreya Medicare has announced a board meeting to review the financial results for the quarter and half-year. The company reports no deviation in the use of its IPO proceeds of Rs. 14.89 Cr. Funds were fully utilized for setting up a hospital through its subsidiary at Valsad (Rs. 7.5 Cr), meeting working capital needs (Rs. 5 Cr), and general corporate expenses (Rs. 1.39 Cr). Partial redemption of non-convertible preference shares (Rs. 0.42 Cr) was carried out, with the balance retained in the bank, reflecting disciplined fund management aligned with operational goals.